Comprehensive Identification of Mutations Responsible for Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA)-to-VISA Conversion in Laboratory-Generated VISA Strains Derived from hVISA Clinical Strain Mu3

A Mutation in the PP2C Phosphatase Gene in a Staphylococcus aureus USA300 Clinical Isolate with Reduced Susceptibility to Vancomycin and Daptomycin

(2012) Karla D. Passalacqua et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature

(2012) Keiichi Hiramatsu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Complete Genome Sequence of Staphylococcus aureus M013, a pvl-Positive, ST59-SCCmec Type V Strain Isolated in Taiwan

(2012) T.-W. Huang et al.   JOURNAL OF BACTERIOLOGY

Structure and function of cytidine monophosphate kinase from Yersinia pseudotuberculosis, essential for virulence but not for survival

(2012) N. J. Walker et al.   Open Biology

Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300

(2012) Susana Gardete et al.   PLoS Pathogens

walKandclpPMutations Confer Reduced Vancomycin Susceptibility inStaphylococcus aureus

(2011) Mitsutaka Shoji et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutation of RNA Polymerase β Subunit (rpoB) Promotes hVISA-to-VISA Phenotypic Conversion of Strain Mu3

(2011) Miki Matsuo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus

(2011) Yukiko Watanabe et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR

(2011) Benjamin P. Howden et al.   PLoS Pathogens

An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus

(2010) L. Cui et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Shuttle Vectors Derived from pN315 for Study of Essential Genes in Staphylococcus aureus

(2010) Miki Matsuo et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Tricarboxylic Acid Cycle-Dependent Synthesis of Staphylococcus aureus Type 5 and 8 Capsular Polysaccharides

(2010) M. R. Sadykov et al.   JOURNAL OF BACTERIOLOGY

Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus

(2010) M. L. Atilano et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

(2009) L. Cui et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The First Vancomycin-Intermediate Staphylococcus aureus Strains Isolated from Patients in Thailand

(2009) A. Lulitanond et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus

(2008) B. P. Howden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification of the First Vancomycin Intermediate-Resistant Staphylococcus aureus (VISA) Isolate from a Hospital in Portugal

(2008) S. Gardete et al.   Microbial Drug Resistance